T helper type 1-autologous dendritic cell vaccine (Baylor College of Medicine)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameT helper type 1-autologous dendritic cell vaccine (Baylor College of Medicine)

Drug Alias Nameautologous dendritic cell vaccine (Baylor College of Medicine)autologous dendritic cell vaccine pulsed pancreatic adenocarcinoma lysate plus mRNA (Baylor College of Medicine)Th-1 dendritic cell vaccine (Baylor College of Medicine)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesDiakonos Oncology Corp

China Registration ClassN/A

Develop Information

Active CompaniesDiakonos Oncology Corp

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A